207 related articles for article (PubMed ID: 28704492)
1. Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.
Mailankody S; Dangeti GV; Soundravally R; Joseph NM; Mandal J; Dutta TK; Kadhiravan T
PLoS One; 2017; 12(7):e0181262. PubMed ID: 28704492
[TBL] [Abstract][Full Text] [Related]
2. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Matsuura E; Umehara F; Hashiguchi T; Fujimoto N; Okada Y; Osame M
J Neurol Sci; 2000 Feb; 173(1):45-52. PubMed ID: 10675579
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis.
Thwaites GE; Simmons CP; Than Ha Quyen N; Thi Hong Chau T; Phuong Mai P; Thi Dung N; Hoan Phu N; White NP; Tinh Hien T; Farrar JJ
J Infect Dis; 2003 Oct; 188(8):1105-15. PubMed ID: 14551879
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency in patients with tuberculous meningitis and its relationship with treatment outcome.
Dangeti GV; Mailankody S; Neeradi C; Mandal J; Soundravally R; Joseph NM; Kamalanathan S; Swaminathan RP; Kadhiravan T
Int J Tuberc Lung Dis; 2018 Jan; 22(1):93-99. PubMed ID: 29297432
[TBL] [Abstract][Full Text] [Related]
5. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
Lee KY; Kim EH; Yang WS; Ryu H; Cho SN; Lee BI; Heo JH
J Neurol Sci; 2004 May; 220(1-2):73-8. PubMed ID: 15140609
[TBL] [Abstract][Full Text] [Related]
6. Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
Majeed S; Singh P; Sharma N; Sharma S
BMC Infect Dis; 2016 Nov; 16(1):722. PubMed ID: 27899068
[TBL] [Abstract][Full Text] [Related]
7. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
Price NM; Farrar J; Tran TT; Nguyen TH; Tran TH; Friedland JS
J Immunol; 2001 Mar; 166(6):4223-30. PubMed ID: 11238675
[TBL] [Abstract][Full Text] [Related]
8. The association between blood-cerebrospinal fluid barrier dysfunction and the therapeutic effect in tuberculous meningitis patients.
Tang J; An Y; Liao Y; Li Y; Li L; Wang L
Eur Neurol; 2014; 71(5-6):331-6. PubMed ID: 24776964
[TBL] [Abstract][Full Text] [Related]
9. Serum matrix metalloproteinase-2 levels indicate blood-CSF barrier damage in patients with infectious meningitis.
Kanoh Y; Ohara T; Kanoh M; Akahoshi T
Inflammation; 2008 Apr; 31(2):99-104. PubMed ID: 18185989
[TBL] [Abstract][Full Text] [Related]
10. Elevated Matrix Metalloproteinase Concentrations Offer Novel Insight Into Their Role in Pediatric Tuberculous Meningitis.
Li YJ; Wilkinson KA; Wilkinson RJ; Figaji AA; Rohlwink UK
J Pediatric Infect Dis Soc; 2020 Feb; 9(1):82-86. PubMed ID: 30753686
[TBL] [Abstract][Full Text] [Related]
11. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.
Thibert KA; Raymond GV; Nascene DR; Miller WP; Tolar J; Orchard PJ; Lund TC
PLoS One; 2012; 7(11):e50430. PubMed ID: 23185624
[TBL] [Abstract][Full Text] [Related]
13. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
[TBL] [Abstract][Full Text] [Related]
14. The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeability.
Ventorp F; Barzilay R; Erhardt S; Samuelsson M; Träskman-Bendz L; Janelidze S; Weizman A; Offen D; Brundin L
J Affect Disord; 2016 Mar; 193():349-54. PubMed ID: 26796235
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis.
van der Flier M; Hoppenreijs S; van Rensburg AJ; Ruyken M; Kolk AH; Springer P; Hoepelman AI; Geelen SP; Kimpen JL; Schoeman JF
Pediatr Infect Dis J; 2004 Jul; 23(7):608-13. PubMed ID: 15247597
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of cerebrospinal fluid matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 concentrations in childhood bacterial meningitis.
Roine I; Pelkonen T; Bernardino L; Lauhio A; Tervahartiala T; Lappalainen M; Kataja M; Pitkäranta A; Sorsa T; Peltola H
Pediatr Infect Dis J; 2014 Jul; 33(7):675-9. PubMed ID: 24445831
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Lactate Concentration in Peripheral Plasma and Cerebrospinal Fluid with Glasgow Outcome Scale for Patients with Tuberculous Meningitis Complicated by Acute Hydrocephalus Treated with Fluid Diversions.
Faried A; Arief G; Arifin MZ; Nataprawira HM
World Neurosurg; 2018 Mar; 111():e178-e182. PubMed ID: 29248780
[TBL] [Abstract][Full Text] [Related]
19. Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.
Tsai HC; Chung LY; Chen ER; Liu YC; Lee SS; Chen YS; Sy CL; Wann SR; Yen CM
Am J Trop Med Hyg; 2008 Jan; 78(1):20-7. PubMed ID: 18187780
[TBL] [Abstract][Full Text] [Related]
20. [Four cases of tuberculous meningitis--clinical significance of pleocytosis with polymorphonuclears as the predominating cell type in CSF].
Ohse H; Saito T; Tajima M; Endo T; Watanabe S; Fukai S; Yanai N; Hasegawa S
Kekkaku; 1996 Sep; 71(9):505-12. PubMed ID: 8914385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
